chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 24.0
Sex: F
Vaccine: FLU4
Symptoms: Abdominal pain upper, Cough, Dyspnoea, Hyperhidrosis, Pallor
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 723905), concerning a 24-year-old, adult female patient. The patient's historical condition included: depressive disorder. Current condition included: T2DM. The patient had no known drug allergies. Concomitant medications included: Escitalopram, LEVEMIR, Metformin and NOVOLOG. On 26-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 01644611A and expiry date: not reported). On the same day, 2 to 3 minutes after vaccination, the patient experienced diaphoretic, became pale and had stomach pain. Hence, she visited examination room 5 minutes after vaccination. The patient stated that, she had trouble breathing, felt shortness of breath, coughing or clearing of her throat. The patient was referred to the allergist. It was reported that, no vital signs were obtained, and no laboratory tests were done. She received BENADRYL (dose: 50 mg via intramuscular route) and Epinephrine (dose: 0.3 mg via intramuscular route. Approximately 1-hour post vaccination and reactions, the patient's condition improved and was sent home. The patient had recovered from all the events. The reporter assessed this case as non-serious.
Age: 24.0
Sex: F
Vaccine: FLU4
Symptoms: Throat irritation
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 723905), concerning a 24-year-old, adult female patient. The patient's historical condition included: depressive disorder. Current condition included: T2DM. The patient had no known drug allergies. Concomitant medications included: Escitalopram, LEVEMIR, Metformin and NOVOLOG. On 26-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 01644611A and expiry date: not reported). On the same day, 2 to 3 minutes after vaccination, the patient experienced diaphoretic, became pale and had stomach pain. Hence, she visited examination room 5 minutes after vaccination. The patient stated that, she had trouble breathing, felt shortness of breath, coughing or clearing of her throat. The patient was referred to the allergist. It was reported that, no vital signs were obtained, and no laboratory tests were done. She received BENADRYL (dose: 50 mg via intramuscular route) and Epinephrine (dose: 0.3 mg via intramuscular route. Approximately 1-hour post vaccination and reactions, the patient's condition improved and was sent home. The patient had recovered from all the events. The reporter assessed this case as non-serious.
Sex: F
Vaccine: FLU4
Symptoms: Immediate post-injection reaction, Injected limb mobility decreased, Injection site pain, Osteoarthritis, X-ray limb abnormal
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 723909), concerns a 52-year-old, adult, female patient. The patient's current condition included allergy to penicillin. The concomitant medications included, over the counter Vitamins for an unknown indication (on an unspecified date). On 08-Sep-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: right arm, batch number: XF31307 and expiry date: not reported). On the same day, the patient experienced immediate pain at injection site followed by difficulty with range of motion of right shoulder and arm. Later, the pain radiated to top of shoulder. After 2-3 weeks of pain, the range of motion was decreased and the patient sought for urgent care and treated with MOTRIN for an unknown indication (on an unspecified date) and prescribed motion exercises. As the pain persisted, the patient advised for X-ray of right shoulder. On 20-Oct-2017, X-ray was performed, and results showed that, minimal to mild degenerative change to the right acromioclavicular joint (AC) joint with slight cephalic elevation of the distal clavicle, consistent with possible traumatic changes and unremarkable appearing in right glenohumeral joint, which reported as normal. On 27-Oct-2017, it was reported that, the patient felt better. On 30-Oct-2017, up on recommendation, the patient went for physical therapy. On an unspecified date, it was reported that, pain was decreased, range of motion was felt better. At the time of the report, the patient had recovered from the events (immediate post-injection reaction, injected mobility decreased and injection site pain). The reporter assessed the case as non-serious. Non-significant case correction received with IRD 21-Feb-2018: Event verbatim was changed from 'immediate post-injection reaction' to 'she experienced immediate pain at site'.
Age: 46.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Asthenia, Burning sensation, Fatigue, Injection site pain
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 723951), concerns a 46-year-old, adult female patient. The patient had illness from unspecified flu vaccine for one or two days in the past. The patient had no medical history or current illness at the time of vaccination. The concomitant medications included ranitidine and ESTRACE. On 25-Oct-2017, the patient was administered with AFLURIA (QIV) (dose: 0.5 ml (reported as unk), route of administration: intramuscular, anatomical location: left arm, batch number: XF32508, expiry date: not reported). On the same, after administration of vaccine, the patient had burning sensation in the arm for 30 min. The patient also experienced severe fatigue, weakness, nausea, sore throat, sore joint and fever for 4 days with spiking temperature of 101 Fahrenheit for hours and 103 Fahrenheit for full 4 days. The patient' arm was sore at injection site for 3 days. At the time of this report, the patient had recovered from the events (burning sensation in the arm, severe fatigue, weakness, nausea, sore throat and joint and fever). The reporter assessed the case as non-serious. Non-significant case correction received with IRD 21-Feb-2018: Narrative was corrected.
Age: 46.0
Sex: F
Vaccine: FLU4
Symptoms: Nausea, Oropharyngeal pain, Pyrexia
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 723951), concerns a 46-year-old, adult female patient. The patient had illness from unspecified flu vaccine for one or two days in the past. The patient had no medical history or current illness at the time of vaccination. The concomitant medications included ranitidine and ESTRACE. On 25-Oct-2017, the patient was administered with AFLURIA (QIV) (dose: 0.5 ml (reported as unk), route of administration: intramuscular, anatomical location: left arm, batch number: XF32508, expiry date: not reported). On the same, after administration of vaccine, the patient had burning sensation in the arm for 30 min. The patient also experienced severe fatigue, weakness, nausea, sore throat, sore joint and fever for 4 days with spiking temperature of 101 Fahrenheit for hours and 103 Fahrenheit for full 4 days. The patient' arm was sore at injection site for 3 days. At the time of this report, the patient had recovered from the events (burning sensation in the arm, severe fatigue, weakness, nausea, sore throat and joint and fever). The reporter assessed the case as non-serious. Non-significant case correction received with IRD 21-Feb-2018: Narrative was corrected.
Sex: F
Vaccine: FLU4
Symptoms: Altered state of consciousness, Chromaturia, Cough, Dizziness, Fatigue
Clinical narrative: This is a spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 723952), concerns a 33-year-old, adult, female patient. The patient had no medical history and allergy. The patient did not receive any concomitant medication. On 23-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 01444621A and expiry date: not reported). On 24-Oct-2017, (reported as Tuesday) after 1 day of vaccination, the patient started to have tickle feeling in her throat which was not as initial symptom normal cold (as reported). On 25-Oct-2017 (reported as Wednesday), she had fatigue, nasal symptoms (congestion and runny nose). On next day 26-Oct-2017 (Thursday), she had cough and was still fatigue. She also could not think sharply. The patient received diphenhydramine hydrochloride at night. On 27-Oct-2017 (Friday), she woke with a headache and dizziness. It was reported that, her husband had to take her son to school as she felt like she would pass out and vomit. She reported that, she felt like she did not breathe well as she slept so she practiced consciously breathing all the day and received acetaminophen, Aspirin and caffeine. She felt fatigued again. It was stated that, she went home, rested and drank water despite of yellow urine (she did not feel dehydrated). On 29-Oct-2017 (Saturday), she felt better and decided to do exercise (jump on trampoline for endorphins. The patient recovered from all the events. The reporter assessed the events as non-serious. Non-significant case correction received with the IRD 21-Feb-2018: The verbatim of the events "activities of daily living impaired", "consciousness disturbed" and "nausea" was corrected.
Sex: F
Vaccine: FLU4
Symptoms: Headache, Nasal congestion, Nausea, Respiration abnormal, Rhinorrhoea
Clinical narrative: This is a spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 723952), concerns a 33-year-old, adult, female patient. The patient had no medical history and allergy. The patient did not receive any concomitant medication. On 23-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 01444621A and expiry date: not reported). On 24-Oct-2017, (reported as Tuesday) after 1 day of vaccination, the patient started to have tickle feeling in her throat which was not as initial symptom normal cold (as reported). On 25-Oct-2017 (reported as Wednesday), she had fatigue, nasal symptoms (congestion and runny nose). On next day 26-Oct-2017 (Thursday), she had cough and was still fatigue. She also could not think sharply. The patient received diphenhydramine hydrochloride at night. On 27-Oct-2017 (Friday), she woke with a headache and dizziness. It was reported that, her husband had to take her son to school as she felt like she would pass out and vomit. She reported that, she felt like she did not breathe well as she slept so she practiced consciously breathing all the day and received acetaminophen, Aspirin and caffeine. She felt fatigued again. It was stated that, she went home, rested and drank water despite of yellow urine (she did not feel dehydrated). On 29-Oct-2017 (Saturday), she felt better and decided to do exercise (jump on trampoline for endorphins. The patient recovered from all the events. The reporter assessed the events as non-serious. Non-significant case correction received with the IRD 21-Feb-2018: The verbatim of the events "activities of daily living impaired", "consciousness disturbed" and "nausea" was corrected.
Sex: F
Vaccine: FLU4
Symptoms: Thinking abnormal, Throat irritation
Clinical narrative: This is a spontaneous case, reported by healthcare professional (other) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 723952), concerns a 33-year-old, adult, female patient. The patient had no medical history and allergy. The patient did not receive any concomitant medication. On 23-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 01444621A and expiry date: not reported). On 24-Oct-2017, (reported as Tuesday) after 1 day of vaccination, the patient started to have tickle feeling in her throat which was not as initial symptom normal cold (as reported). On 25-Oct-2017 (reported as Wednesday), she had fatigue, nasal symptoms (congestion and runny nose). On next day 26-Oct-2017 (Thursday), she had cough and was still fatigue. She also could not think sharply. The patient received diphenhydramine hydrochloride at night. On 27-Oct-2017 (Friday), she woke with a headache and dizziness. It was reported that, her husband had to take her son to school as she felt like she would pass out and vomit. She reported that, she felt like she did not breathe well as she slept so she practiced consciously breathing all the day and received acetaminophen, Aspirin and caffeine. She felt fatigued again. It was stated that, she went home, rested and drank water despite of yellow urine (she did not feel dehydrated). On 29-Oct-2017 (Saturday), she felt better and decided to do exercise (jump on trampoline for endorphins. The patient recovered from all the events. The reporter assessed the events as non-serious. Non-significant case correction received with the IRD 21-Feb-2018: The verbatim of the events "activities of daily living impaired", "consciousness disturbed" and "nausea" was corrected.
Age: 60.0
Sex: F
Vaccine: FLU4, PPV
Symptoms: Gait disturbance, Injection site swelling, Muscular weakness, Musculoskeletal pain
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724056), concerns a 60-year-old, adult, female patient. On an unspecified date, a couple of years ago, the patient had brain aneurysm and the patient had no known allergies. The concomitant medications included DILANTIN and Dicyclomine (on an unspecified date). On 27-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (1 as reported), route of administration: intramuscular, anatomical location: left arm, batch number: 01044611A and expiry date: not reported) and non-company suspect product PNEUMOVAX (dose: 1 (as reported), route of administration: intravascular, anatomical location: left arm, batch number: N020502 and expiry date: not reported). On the same day, after vaccination, the patient had trouble in walking. As she had muscle weakness, her husband had helped her with walking. The patient also had pain in her shoulder and swelling at injection site. On 30-Oct-2017, on fourth day of reaction, the patient informed to pharmacy. On the next day, the patient felt much better and reported that, her appointment with neurologist was scheduled on 07-Nov-2017. At the time of the report, the outcome of the events (muscle weakness, shoulder pain, injection site swelling and difficulty in walking) were unknown. The reporter assessed the case as non-serious.
Age: 64.0
Sex: F
Vaccine: FLU4
Symptoms: Acupuncture, Headache, Injection site pain, Neck pain, Nerve compression
Clinical narrative: This spontaneous case, reported by other non-healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724118) concerns a 64-year-old, adult, female patient. The patient's historical conditions included osteopenia and arthritis. The patient's vaccination history included unspecified influenza vaccine and its adverse events, injection site pain, pain at base of skull and pinched nerve. The patient's current conditions included hypothyroidism (since and unspecified date), high blood pressure (since an unspecified date). The patient's surgical procedure included gall bladder removed (09-Jul-2017) and sulfa allergy (since an unspecified date). The concomitant medications included multivitamin, SYNTHROID and unspecified blood pressure medications. On 29-Sep-2017, the patient was administered with AFLURIA QUADRIVALENT (dose:0.5 ml, route of administration: right arm, anatomical location, batch number, expiry date: not reported). On 30-Sep-2017, the next day of vaccination, the patient experienced pain at injection site and a jolt which dispelled into her system up neck and base of skull. The patient reported that for the next 3 weeks, she had continuous pain at the injection site and base of the skull (rated as 3 to 7 on pain scale). The patient used unspecified medications for pain, had massages and acupuncture. On an unspecified date, the pain had receded. On 20-Oct-2017, the patient consulted a chiropractor/ massage therapist and the pain was resolved. At the time of this report, the patient had recovered from the events injection site pain, pain at base of the skull and pinched nerve. The reporter assessed the events as non-serious. Significant case correction received with IRD 21-Feb-2018: The as determined causality of the events (Pinched nerve and Headache) was corrected from the unassessable to related. The case comment was amended accordingly.
Age: 49.0
Sex: F
Vaccine: FLU4
Symptoms: Bursitis, Injection site pain, Insomnia, Musculoskeletal pain, Paraesthesia
Clinical narrative: This spontaneous case, reported by healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724122), concerns a 49-year-old, adult female patient. The patient's historical condition included back pain (dates not reported). The patient was allergic to latex and AMBIEN. Concomitant medication included vitamin D, duloxetine and meloxicam. On 18-Oct-2017, the patient was vaccinated with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: right arm, batch number: XF33108 and expiry date: not reported). On the same day, after the vaccination, the patient experienced tingling up to neck and down arm to below. The patient also experienced continual pain and aching to shoulder area. Reportedly, the pain continued to right shoulder keeping her awake at night. Consequently, on 24-Oct-2017, the patient was seen in clinic on an unspecified date the patient was diagnosed with right shoulder bursitis post injection. She was treated with ice application (3 to 4 times a day) and with ibuprofen (tablet, 200 mg, two tablets four times a day). At the time of this report, the patient had not recovered from the events. The reporter assessed this report as non-serious.
Age: 26.0
Sex: F
Vaccine: FLU4
Symptoms: Bursitis, Immediate post-injection reaction, Injection site reaction, Pain, Pain in extremity
Clinical narrative: This spontaneous case, reported by healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus (VAERS ID: 724138), concerns a 26-year-old, adult female patient. Since an unspecified date, the patient was allergic to amoxicillin. The patient did not have any current illness and was not taking any concomitant medication. On 18-Oct-2017, the patient was vaccinated with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as UNK), route of administration: intramuscular, anatomical location: left arm, batch number: XF33108 and expiry date: not reported). On the same day (18-Oct-2017) after the vaccination, the patient experienced instant pain in entire arm which continued with movement and lifting. Consequently, on 30-Oct-2017, the patient was seen in clinic and on an unspecified date, the patent was diagnosed with left shoulder bursitis post injection (shoulder bursitis). She was treated with ice application (2 to 3 times a  day) and with ibuprofen (tablets, 400 mg, three times a day). At the time of this report, the patient had not recovered from the events. The reporter assessed this report as non-serious.
Age: 61.0
Sex: F
Vaccine: FLU4
Symptoms: Injection site pain, Joint range of motion decreased, Pain
Clinical narrative: This spontaneous case, reported by healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724166), concerns a 61-year-old, adult female patient. The patient's medical history was not reported. Concomitant medications included Probiotic, vitamin D, calcium, magnesium, fish oil, vitamin E and AREDS vitamin. On 06-Sep-2017, the patient was vaccinated with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as 1), route of administration: intramuscular, anatomical location: left arm, batch number: XF31307 and expiry date: not reported). On the same day after vaccination, the patient experienced left shoulder pain. Reportedly, the left shoulder pain has persisted since the vaccination. The patient also had decreased range of motion, pain on abduction, adduction, external rotation, forward flexion and extension. At the time of this report, the patient had not recovered from the events. Health authority assessed this report as non-serious.
Sex: F
Vaccine: FLU4
Symptoms: Asthenia, Injection site pain, Loss of personal independence in daily activities, Musculoskeletal discomfort, Pain
Clinical narrative: This spontaneous case, reported by other non-health care professional to VAERS and initially retrieved on 21-Feb-2018 by Sequris from VAERS (VAERS ID: 724), concerns a 56-year-old, adult, female patient. The patient's historical vaccine included small pox vaccine which was administered on an unspecified date in 2004 and had myocarditis for 10 days and on unspecified date the patient received influenza vaccine and had shoulder discomfort. The patient's current conditions were not reported. The patient's concomitant medications included MOTRIN, Vitamin D, probiotic, potassium, gabapentin and hormone replacements for an unknown indication. On 06-Sep-2017, the patient was administered with AFLURIA QUADRIVALENT (dose:0.5, route of administration: intramuscular, anatomical location: left arm, batch number: XF31307 and expiry date: not reported). On 07-Sep-2017, 01 day after the vaccination, the patient developed pain in left shoulder which was still ongoing. Reportedly, on an unspecified date in 2017, first week after vaccination, the patient also experienced shoulder discomfort which was described as an event which happened previously with flu vaccine. On second week, the patient reported that she had extreme pain and due to which she was unable to undress. Subsequently, on fourth week, she developed extreme pain and weakness which effected her daily activities (reported as she was unable to blow dry her hair). On sixth week, she experienced pain in the arm when rotated or extended during aerobic exercise and also during weight lifting. Reportedly, at the time of this report (almost 60 days later), the pain still existed with full arm extension with improvement. At this time of the report, the outcome of the events was not recovered. The reporter considered the case as non-serious. Non-significant case correction received with IRD 21-FEB-2018: Case comment was corrected.
Sex: F
Vaccine: FLU4
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case, reported by other non-health care professional to VAERS and initially retrieved on 21-Feb-2018 by Sequris from VAERS (VAERS ID: 724), concerns a 56-year-old, adult, female patient. The patient's historical vaccine included small pox vaccine which was administered on an unspecified date in 2004 and had myocarditis for 10 days and on unspecified date the patient received influenza vaccine and had shoulder discomfort. The patient's current conditions were not reported. The patient's concomitant medications included MOTRIN, Vitamin D, probiotic, potassium, gabapentin and hormone replacements for an unknown indication. On 06-Sep-2017, the patient was administered with AFLURIA QUADRIVALENT (dose:0.5, route of administration: intramuscular, anatomical location: left arm, batch number: XF31307 and expiry date: not reported). On 07-Sep-2017, 01 day after the vaccination, the patient developed pain in left shoulder which was still ongoing. Reportedly, on an unspecified date in 2017, first week after vaccination, the patient also experienced shoulder discomfort which was described as an event which happened previously with flu vaccine. On second week, the patient reported that she had extreme pain and due to which she was unable to undress. Subsequently, on fourth week, she developed extreme pain and weakness which effected her daily activities (reported as she was unable to blow dry her hair). On sixth week, she experienced pain in the arm when rotated or extended during aerobic exercise and also during weight lifting. Reportedly, at the time of this report (almost 60 days later), the pain still existed with full arm extension with improvement. At this time of the report, the outcome of the events was not recovered. The reporter considered the case as non-serious. Non-significant case correction received with IRD 21-FEB-2018: Case comment was corrected.
Age: 58.0
Sex: F
Vaccine: FLU4
Symptoms: Dysphagia, Pharyngeal oedema
Clinical narrative: This is a spontaneous case, reported by other non-healthcare professional (consumer) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724183), concerns a 58-year-old, adult, female patient. On 28-Sep-2017, (reported as around 4:15 PM), the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration, anatomical location: left arm, batch number: 00844611A and expiry date: not reported). On the same day, after several hours of vaccination, the patient had throat swelling and she could not swallow. At 7:30, she was in emergency room for the events, where she received steroid, BENADRYL and felt better. Around 11:45 PM, the patient went to home. The patient had recovered from the events. The reporter assessed the event as non-serious.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Arthralgia, Immediate post-injection reaction, Insomnia, Joint range of motion decreased, Pain
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724214), concerns a 50-year-old, adult, female patient. The patient's medical history was not reported. Concomitant medication included FLONASE NASAL SPRAY and multivitamin. On 18-Oct-2017, the patient was vaccinated with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: reported as SYR, batch number: 00544611A, anatomical location and expiry date: not reported). On the same day after vaccination, the patient's right shoulder joint was immediately sore. Reportedly, after two weeks pain was worse than it was at the time of injection. The patient's range of motion was severely limited with her right arm due to the pain in the shoulder joint which radiated down the arm. Reportedly, doing simple tasks like getting dressed also caused pain and sleeping has also been affected. The patient had also made an appointment with orthopaedic doctor since the pain had not subsided. At the time of this report, the patient had not recovered from the events. The reporter considered this case as non-serious.
Age: 50.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724214), concerns a 50-year-old, adult, female patient. The patient's medical history was not reported. Concomitant medication included FLONASE NASAL SPRAY and multivitamin. On 18-Oct-2017, the patient was vaccinated with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: reported as SYR, batch number: 00544611A, anatomical location and expiry date: not reported). On the same day after vaccination, the patient's right shoulder joint was immediately sore. Reportedly, after two weeks pain was worse than it was at the time of injection. The patient's range of motion was severely limited with her right arm due to the pain in the shoulder joint which radiated down the arm. Reportedly, doing simple tasks like getting dressed also caused pain and sleeping has also been affected. The patient had also made an appointment with orthopaedic doctor since the pain had not subsided. At the time of this report, the patient had not recovered from the events. The reporter considered this case as non-serious.
Sex: F
Vaccine: FLU4
Symptoms: Discomfort, Erythema, Injected limb mobility decreased, Injection site pain, Oedema peripheral
Clinical narrative: This spontaneous case, reported by other non-health professional VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724306), concerning a 50-year-old female patient. The patient's historical condition included: hypercholesterolemia. The patient was allergic to penicillin. Concomitant medications included: Atorvastatin, Lisinopril, HCTZ, Fish oil, Primrose oil, Vitamin d, Black cohosh, Multivitamin all for an unknown indication. On 30-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 1544611A, expiry date: not reported). On the same day, several hours after receiving the shot, the patient's left upper forearm was extremely sore and very sore and warm to touch. On the following day, left arm was even more painful and had extreme pain from top to bottom of the left upper arm and shoulder area, including significant swelling in her underarm area and next to the left breast. It was difficult to move her arm in any direction and was still very warm to touch with noticeable redness, including sensitivity to slightest touch. The patient's arm was still very sore, warm to touch with visible redness, swelling was still noticeable in underarm area and very uncomfortable. It was reported that, the patient made physician's office visit. The patient had recovered from all the events. The reporter assessed the events as non-serious.
Sex: F
Vaccine: FLU4
Symptoms: Pain in extremity, Skin warm, Tenderness
Clinical narrative: This spontaneous case, reported by other non-health professional VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724306), concerning a 50-year-old female patient. The patient's historical condition included: hypercholesterolemia. The patient was allergic to penicillin. Concomitant medications included: Atorvastatin, Lisinopril, HCTZ, Fish oil, Primrose oil, Vitamin d, Black cohosh, Multivitamin all for an unknown indication. On 30-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: 1544611A, expiry date: not reported). On the same day, several hours after receiving the shot, the patient's left upper forearm was extremely sore and very sore and warm to touch. On the following day, left arm was even more painful and had extreme pain from top to bottom of the left upper arm and shoulder area, including significant swelling in her underarm area and next to the left breast. It was difficult to move her arm in any direction and was still very warm to touch with noticeable redness, including sensitivity to slightest touch. The patient's arm was still very sore, warm to touch with visible redness, swelling was still noticeable in underarm area and very uncomfortable. It was reported that, the patient made physician's office visit. The patient had recovered from all the events. The reporter assessed the events as non-serious.
Age: 51.0
Sex: M
Vaccine: FLU4
Symptoms: Hypoaesthesia, Pain in extremity
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724382), concerns a 51-year-old, adult male patient. The patient's current conditions included acid reflux, hypertension, migraine and penicillin allergy. The patient's concomitant medications included losartan, omeprazole and sumatriptan. The patient had no current illness. On 31-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as unknown), route of administration: intramuscular, anatomical location: other (reported as OT), batch number: XF33008, expiry date: not reported). On the same day, the patient had pain in arm and numbness. The patient had not recovered from the events (arm pain and numbness). The reporter assessed the case as non-serious.
Age: 33.0
Sex: F
Vaccine: FLU4
Symptoms: Arthralgia, Nuclear magnetic resonance imaging, Product administered at inappropriate site
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724419), concerning a 33-year-old, adult female patient. The patient's historical condition included, colitis. The patient was allergic to wheat and dairy. Concomitant medications included, CANASA and probiotics. On 13-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as 3 dose), route of administration: intramuscular, anatomical location: right arm, batch number: XF31107A, expiry date: not reported). It was reported that, shot was given high but had no muscle discomfort initially (explicitly coded as drug administered at inappropriate site). On the following day(14-Oct-2017), the patient had deep joint pain. On 01-Nov-2017, the patient underwent MRI (magnetic resonance imaging) but the result was not reported. At the time of this report, the patient had not yet recovered from the event joint ache. The reporter assessed the event joint ache as non-serious.
Sex: M
Vaccine: FLU4
Symptoms: Immediate post-injection reaction, Injection site induration, Injection site swelling
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724451), concerns a 57-year-old, adult, male patient. The patient had no medical history and no history of allergies. The patient's concomitant medication included cetirizine. On 01-Nov-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5ml, route of administration: intramuscular, anatomical location: left arm, batch number: XF32908 and expiry date: not reported). On the same day, immediately after vaccination, the patient's skin became hard and swollen at around 1/2 in diameter beneath the skin at the injection site. The outcome of the events was unknown. The reporter assessed the case as non-serious.
Sex: M
Vaccine: FLU4
Symptoms: Angiopathy, Blood pressure measurement, Chills, Dizziness, Feeling abnormal
Clinical narrative: This is spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724511), concerns a 38-year-old, adult male patient. The patient's did not receive flu shot in the past. At biometric screening, before taking shot, the patient's blood pressure was 128/78. The patient's other medical history was not reported. On 23-Oct-2017, the patient received AFLURIA QUADRIVALENT (dose: 0.5ml, (unk as reported), batch number: 01344611A, anatomical location: left arm, route of administration: intramuscular). On the same day, after administration of vaccine, the patient found pale and dizzy. The patient was laid on the ground with his legs elevated. The patient was chilled with diaphoresis. The blood pressure of the patient was 102/72. After 10 minutes, the patient complained of feeling weird. Nurse suggested to patient for a walk in the clinic. The patient felt much and was diagnosed with vascular response to the injection. The outcome of the events (angiopathy, pallor, feeling abnormal, hyperhidrosis, feeling cold, dizziness) was recovered. The reporter assessed the case as non-serious.
Sex: M
Vaccine: FLU4
Symptoms: Hyperhidrosis, Pallor
Clinical narrative: This is spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724511), concerns a 38-year-old, adult male patient. The patient's did not receive flu shot in the past. At biometric screening, before taking shot, the patient's blood pressure was 128/78. The patient's other medical history was not reported. On 23-Oct-2017, the patient received AFLURIA QUADRIVALENT (dose: 0.5ml, (unk as reported), batch number: 01344611A, anatomical location: left arm, route of administration: intramuscular). On the same day, after administration of vaccine, the patient found pale and dizzy. The patient was laid on the ground with his legs elevated. The patient was chilled with diaphoresis. The blood pressure of the patient was 102/72. After 10 minutes, the patient complained of feeling weird. Nurse suggested to patient for a walk in the clinic. The patient felt much and was diagnosed with vascular response to the injection. The outcome of the events (angiopathy, pallor, feeling abnormal, hyperhidrosis, feeling cold, dizziness) was recovered. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLU4
Symptoms: Disorientation, Fatigue, Pain in extremity, Visual impairment
Clinical narrative: This is spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724518), concerns a 37-year-old, adult female patient. The patient's historical condition included asthma and no allergies were reported. On 12-Oct-2017, the patient received AFLURIA QUADRIVALENT (dose: 0.5ml (1 as reported), batch number: XF32908, anatomical location: unknown, route of administration: intramuscular). On the same day, at 01:30pm, the patient felt extremely tired. Around 2:30pm the patient had a feeling of disorientation where he felt like the room became fuzzy. It was reported that, the patient's boss brought her a glass of water. She was slightly worried about driving home, hence she stayed at work until about 4:30. It was stated that, the patient has more pain in her arm than the usual from the flu shot. The patient reached home and went to bed early. The patient felt better from the next day. It was reported that, the patient did not require any further treatment, as she felt better within 24hours. At the time of this report, the patient recovered from the events. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLU4
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724542), concerns a 58-year-old, adult, female patient. The patient's historical condition included Grave's disease. The patient's current conditions, allergies and concomitant medications were not reported. On 12-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, batch number: XF32908, anatomical location and expiry date: not reported). On the same day, after the vaccination, the patient felt achy, fever and fatigue for 2 days. No lab investigation was done. On an unspecified date, the patient had recovered from the events without the treatment. The reporter assessed the events as non-serious. Non-significant case correction received 21-Feb-2018: Case comment was corrected.
Age: 54.0
Sex: F
Vaccine: FLU4
Symptoms: Asthma
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724584), concerns a 54-year-old, adult female patient. The patient's medical history, current illness and medications at the time of vaccination were unknown. On 11-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as unknown), route of administration: intramuscular, anatomical location: left arm, batch number: XF31107A, expiry date: not reported). On the same day, the patient had exacerbation of asthma and was admitted to the emergency room. At the time of this report, the patient had recovered from the event (exacerbation of asthma). The reporter assessed the case as non-serious.
Age: 52.0
Sex: F
Vaccine: FLU4
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724619), concerning a 52-year-old, adult female patient. The patient's medical history, current illness, allergies and concomitant medications were unknown. On 28-Sep-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as 7+), route of administration: intramuscular, anatomical location: left arm, batch number: XF31107A, expiry date: not reported). On the same day, after vaccination, the patient developed pain which was radiating to elbow within 30 minutes (pain in arm). The patient had recovered from the event pain in arm. The reporter assessed the event pain in arm as non-serious.
Age: 54.0
Sex: F
Vaccine: FLU4
Symptoms: Pain in extremity
Clinical narrative: This spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724623), concerns a 54-year-old, adult female patient. The patient's historical drug included ibuprofen for unknown indication, which caused gastric distress. The patient's current condition and concomitant medication were unknown. On 28-Sep-2017, the patient was administered with AFLURIA QUADRIVALENT (dose:0.5ml (reported as 7+), route of administration: intramuscular, anatomical location: left arm, batch number: XF31107A and expiry date: not reported). On the same day after 1 hour of vaccination, the patient had radiating pain down the arm. The patient consulted the physician. The outcome of the event was unknown. The reporter assessed the case as non-serious. Non-significant case correction received on 21-Feb-2018: In events tab, onset latency of the event pain in extremity was changed from 1 day to 1 hour.
Sex: F
Vaccine: FLU4
Symptoms: Blood glucose increased, Hyperhidrosis
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724626), concerns a 48-year-old, adult, female patient. The patient had no known allergies (reported as NKDA). The current condition included diabetes (from an unspecified date). The concomitant medications were unknown. On 27-Sep-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml (7+ as reported), route of administration: intramuscular, anatomical location: left arm, batch number: XF31107A and expiry date: not reported). On the same day evening, the patient had sweating and high blood sugar. At the time of the report, the patient had recovered from the events (blood sugar increased and sweating). The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLU4
Symptoms: Rash
Clinical narrative: This spontaneous case, reported by other non-health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724865), concerns a 28-year-old, adult female patient. The patient's medical history was not reported. Since an unspecified date, the patient had allergy to KEFLEX, latex and milk products. Concomitant medication included Lisinopril for an unknown indication. On 26-Sep-2017, the patient was vaccinated with AFLURIA QUADRIVALENT (dose: 0.5 ml (reported as N/A), route of administration: intramuscular, batch number: XF31407, anatomical location: right arm and expiry date: not reported). On the same day after vaccination, the patient had rash on the right arm which was treated with BENADRYL (twice a day) and with an unspecified cream. On an unspecified date, the patient had recovered from the event. The reporter considered this report as non-serious.
Age: 36.0
Sex: F
Vaccine: FLU4
Symptoms: Dyspnoea, Erythema, Laboratory test, Swelling, Urticaria
Clinical narrative: This spontaneous case, reported by health care professional (other) to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724868), concerns a 36-year-old, adult, female patient. The patient's medical history and concomitant medications were unknown. On 21-Sep-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: left arm, batch number: XF31407 and expiry date: not reported). On 22-Sep-2017, after 1 day of vaccination, the patient had severe hives on back, thigh, buttocks (butt as reported), face, legs, feet, hands and arms were swollen red. The patient also had some trouble in breathing. It was reported that, an unspecified lab tests were performed and results were not reported. At the time of the report, the patient had recovered from the events (difficulty breathing, hives, redness and swelling). The reporter assessed the case as non-serious.
Age: 1.0
Sex: F
Vaccine: FLU4, HEPA, MMR, VARCEL
Symptoms: Rash generalised, Rash pustular, Streptococcus test
Clinical narrative: This spontaneous case, reported by other health professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724879), concerning a 01-year-old, infant female patient. The patient had no medical history, current illness and no allergies. The patient did not receive any concomitant medications. On 23-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, anatomical location: leg, batch number, expiry date: not reported). On the same day, the patient was administered with non-company suspect drug hepatitis A vaccine (dose: 1 DF, route of administration: intramuscular, anatomical location: leg, batch number, expiry date: not reported), MMR II (dose: 1 DF, route of administration: intramuscular, anatomical location: leg, batch number, expiry date: not reported); VARIVAX (dose: 1 DF, route of administration: oral, anatomical location: mouth (as reported), batch number, expiry date: not reported). On 02-NOV-2017, after 10 days of vaccination, the patient developed rash in the whole body with multiple dots that looked like pox. The patient had rapid streptococcal test done, however the results were not reported. At the time of this report, the patient had not yet recovered from the all events. The reporter assessed the events as non-serious.
Sex: F
Vaccine: FLU4
Symptoms: Injected limb mobility decreased, Injection site pain, Sleep disorder
Clinical narrative: This spontaneous case, reported by Other Health Professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724920), concerns a 35-year-old, adult female patient. The patient's medical history was not reported. On 11-Oct-2017, at 10:30 hours, the patient received AFLURIA QUADRIVALENT (dose: 0.5ml, batch number 01144611A, anatomical location: right arm, route of administration: intramuscular). On the same day, the patient had pain in right shoulder, throughout the day the pain worsened and limited her range of motion. The pain also caused some sleep disturbance. It was reported that, the patient tried some range of motion exercises with minimal improvement. Abduction was limited at 30 degrees on the next day and was slightly better on that day around 45 degrees. The outcome of the events was unknown. The reporter assessed the case as non-serious.
Sex: F
Vaccine: FLU4
Symptoms: Asthenia, Joint range of motion decreased, Musculoskeletal pain
Clinical narrative: This is a spontaneous case, reported by other healthcare professional to VAERS and initially retrieved on 21-Feb-2018 by Seqirus from VAERS (VAERS ID: 724926), concerns a 56-year-old, adult female patient. The patient's medical history, allergy and concomitant mediation were not reported. On, 05-Oct-2017, the patient was administered with AFLURIA QUADRIVALENT (dose: 0.5 ml, route of administration: intramuscular, batch number: XF32908, anatomical location and expiry date: not reported). On 06-Oct-2017, after 2 days of vaccination, the patient had shoulder pain, decreased range of motion and shoulder weakness, which lasted for 9 days. On an unspecified date, the patient had recovered from the events. The reporter assessed the events as non-serious.